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Abstract 
The purpose of this research was that of comparing the differences in the quality of life at three groups of patients, one comprised 
of individuals diagnosed with acute leukemia, the second one including individuals with anxiety disorders and the third one with 
individuals with depression. The participants (N=593) were asked to fill in the questionnaire of the quality of life assessment
elaborated by the World Health Organization (WHOQOL). The data gathered were processed on the base Anova One Way and 
as a planned contrast. The results obtained showed significant differences among the three groups compared. The group of the 
individuals with leukemia obtained significantly weaker results on the physical dimension and significantly stronger results on
the psychological, environmental and social relations dimensions. Still for the patients with leukemia, depending on the groups of 
treatment they belong (induction, re-induction and consolidation) important variations were noted for all WHOQOL dimensions. 
© 2014 The Authors. Published by Elsevier Ltd. 
Selection and peer-review under responsibility of PSI WORLD 2013 and their Guest Editors: Dr Mihaela Chraif, Dr Cristian 
Vasile and Dr Mihai Anitei. 
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1. Introduction 
There are many voices that underlie the idea that improvement in quality of life (QoL) is a relevant endpoint for 
the patients affected by leukemia (Molica, 2005). Literally the quality of life for the patients affected by leukemia is 
seen from different points of view. Some studies are concerned by the definition of the concept, by searching ways 
of operating suitable for the patients with leukemia (Cella et al., 2012, Watson, 1996). Other studies are analyzing 
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the dimensions which describe and predict a certain level of the quality of life for the patients with leukemia (Arnold 
et al., 2009; Trask et al., 2013). Another category of studies is concerned by finding new ways of treatment in order 
to improve the quality of life for these patients (Else et al, 2012; Saini et al., 2011; Zent, 2012).Kanellopoulos et al. 
(2013) observe that for the long term survivals, the variables related to health such as fatigue, anxiety, depression 
and insomnia were correlated with a low QoL. In another study dedicated to the exploitation of QoL, Holzner  et al. 
(2004) were comparing the patients with leukemia, establishing that they scored significantly lower for all QoL 
dimensions compared to a control group (healthy individuals). The authors did not discover any differences in QoL 
dimensions between the patients with leukemia who initiated the chemotherapy compared to the ones who had 
already started it. 
As already known, the QoL at patients with leukemia is affected by the appearance of depression and anxiety. 
These are common responses to a cancer diagnosis and subsequent treatment with anticancer medication. Often, the 
patients feel overwhelmed by this condition of cancer. During this research we were concerned by the following 
question: “If the QoL profile of the patients with acute leukemia is different than the one of the patients diagnosed 
with anxiety and depression disorders”. We thus formulated the following two hypotheses: H1: The quality of life 
measured with WHOQOL is perceived differently depending on the diagnosed disease: acute leukemia, anxiety and 
depression. H2: The quality of life at patients with acute leukemia varies significantly depending on the phase of 
treatment. 
2. Method 
2.1. Participants and procedure 
The total sample of the research consisted of 593 individuals hospitalized in a clinic for treatment, a percentage 
of 51.4% being men. Out of the total of individuals who had been medically investigated, a number of 327 were 
diagnosed with acute leukemia (LAL or LAM), thus following a chemotherapeutic treatment. Depending on the 
stage of the disease (initial, relapse and remission) the patients were divided into three groups, formed according to 
the criteria of the phase of the treatment: Induction group (N=117), Re-induction group (N=112), Maintenance 
group (N=98). The rest of the individuals represented the group of patients with psychiatric diagnosis of anxiety 
(N=135) and depression (N=131). The average age of the group with leukemia was of 51.16 years (Std.Dev.= 14.8), 
and for those with psychiatric disorders of 48.23 years (Std.Dev.=12.14).  
2.2. Measures
A specialist hematologist diagnosed the cases of acute leukemia. The group of the patients with acute leukemia 
was made up only of individuals with LAL or LAM diagnosis. And a specialist psychiatrist diagnosed the cases of 
anxiety or depression, according to DSM-IV-R criteria. The individuals of this group received a specialized 
pharmacological treatment for one of the following diseases: anxiety disorder, panic disorder, generalized anxiety 
disorder, health anxiety (hypochondria), undifferentiated somatoform disorder, recurrent depression disorder with an 
average length duration episode. All the individuals were asked to fill in the questionnaire of the life quality 
assessment elaborated by the World Health Organization (WHOQoL). The questionnaire contains 24 items grouped 
on 4 domains (Physical health, Psychological, Social relations and Environment), the result being evaluated on the 
five-level Likert scale. 
2.3. Data analysis 
For testing our hypothesis we used the analysis of variance (ANOVA). More specifically we tested if the disease 
type (acute leukemia, anxiety and depression) differs significantly from the aspect of the level of the quality of life 
reported to the 4 dimensions operated on the WHOQoL scale. 
Planned contrast was used to test the potential differences between the three groups, at the level of the first 
hypothesis, and between the three phases of treatment at the level of the second hypothesis. 
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3. Results 
In the table below we are presenting the means and the standards deviations for the groups compared: acute 
leukemia (induction, re-induction, or consolidation), anxiety and depression. 
Table 1. Mean level of WHOQOL dimensions for acute leukemia, anxiety and depression groups 
Group 
Physical health Psychological Social relations Environment 
Mean Std. Dev. Mean Std. Dev. Mean Std. Dev. Mean Std. Dev. 
Acute 
leukemia 
aggregate level 17.31 5.31 18.78 5.74 8.77 2.89 19.93 5.41 
Induction phase 18.38 3.97 18.71 3.77 9.80 2.73 24.44 4.12 
Re-induction 
phase 
12.91 3.20 13.70 3.91 7.54 2.57 17.64 4.69 
Consolidation 
phase 
21.08 5.10 24.67 3.37 8.96 2.91 17.17 3.82 
Anxiety 
21.18 4.33 14.11 3.12 6.46 1.63 16.37 2.91 
Depression 
18.50 4.00 13.18 3.39 5.85 1.19 16.20 2.49 
First  hypothesis  was  confirmed  by  ANOVA  results,  as  long  as  for  all  four  dimensions  of  QOL  there  were  
discovered significant differences between the medical groups. Thus, the physical health was different across the 
three groups F (2, 590) = 30.66, p<.001, with an overall small effect size of r =.31. Planned contrast reveled that 
physical health is significantly lower in the group of acute leukemia compared to depression and anxiety group       
t (590) = 6.32, p<.001, r=.25, and significantly higher in anxiety group compared with depression group t (590) = -
4.51, p<.001, r=.18.  
The perceived psychological quality of life was different across the three groups F (2, 590) = 85.06, p<.001, with  
an overall medium effect size of  r =.47. For the psychological dimension, planned contrast revealed a significantly 
higher quality of life reported by the group with acute leukemia, compared with anxiety and depression group 
t(590)= -12.97, p<.001, r=.47. The contrast between anxiety and depression group was insignificant t (590)= -1.57, 
p>.05. 
The quality of social relations was different across the three groups F (2, 590) = 92.59, p<.001, with an overall 
medium effect  size  of  r  =.49.  In  this  case  planned contrast  revealed  a  significantly  higher  quality  reported  by  the  
group with acute leukemia, compared with anxiety and depression group t (590)= -13.48, p<.001, r=.49. The 
contrast between anxiety and depression group was also significant t (590) = -2.08, p<.05, but the effect was weak 
r=.09. 
 Finally, the quality of environmental conditions was also different across the three groups F (2, 590) = 50.17, 
p<.001, with an overall small effect size of r =.38. The contrast analysis revealed here a significantly higher quality 
reported by the group with acute leukemia, compared with anxiety and depression group t (590) = -10.02, p<.001, 
r=.38. The contrast between anxiety and depression group was insignificant t (590) = -.31 p>.05.  
Regarding the second hypothesis the ANOVA results showed significant differences for all 4 dimensions of the 
quality of life assessment. Thus at the level of the dimension physical health the value was F (2, 324) = 109.18, 
p<.001, with an overall big effect size of   r=.63. Planned contrast analysis performed in this case compared in the 
first place the induction and re-induction groups with the consolidation one, and secondly the induction group with 
the re-induction group. 
For the physical health the first contrast was significant t(324)= -10.93, p<.001, r=.52, showing that the patients 
with acute leukemia in the consolidation phase present a better quality of life compared with the induction and re-
induction groups. The second contrast was also significant t (324) = -10.05, p<.001, r=.49, proving a weaker quality 
of physical health for the patients in the re-induction phase. 
For the perceived psychological quality of life, strong differences were obtained F(2, 324) = 229.34, p<.001, r 
=.77. Planned contrast revealed that the group of patients in the consolidation phase is significantly better positioned 
than the groups of induction and re-induction t (324) = -18.94, p<.001, r=.72. The contrast between these last two 
showed that the patients in the re-induction phase are reporting a weaker psychological quality of life than the ones 
in the induction phase: t(324)= -10.23, p<.001, r=.49. 
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A different configuration of the data was registered for the quality of social relations F (2, 324) = 19.97, p<.001, r 
=.33. In this case, the first planned contrast revealed that the patients with acute leukemia in the consolidation phase 
do not register better scores than those in the induction and re-induction phases t (324) = -.877, p>0.5. The second 
planned contrast showed that the patients in the induction phase reported a better quality of social relations than the 
ones in the re-induction phase t (324) = -6.27, p<.001, r=.33. 
Finally, for the quality of environmental conditions the ANOVA test emphasized significant differences F (2, 
324) = 103.01, p<.001, r =.62. First planned contrast revealed that the patients in the consolidation phase perceive a 
weaker quality of the environment compared to the ones in the induction and re-induction phases t (324) = 7.55, 
p<.001, r=.39. The second planned contrast underlined the fact that the patients in the re-induction phase reported 
lower scores here than the ones in the induction phase: t (324) = -12.11, p<.001, r=.56. 
4. Discussion and conclusions 
The results of the research, with small exceptions, confirm the hypotheses we have initially formulated. Thus the 
quality of life perceived depends on the type of the disease. As expected, the physical aspect of the quality of life is 
perceived in a worse manner by the patients with acute leukemia and with depression. It is interesting the fact that 
the patients with acute leukemia are reporting better levels of the quality of mental, social and environmental life, 
compared to the patients with anxiety and depressive disorders. Still the supplementary comparisons made among 
the patients with acute leukemia, depending on the treatment phase, pointed out extremely powerful variations. As a 
rule, the group of patients in the re-induction phase is reporting a lower level of the quality of life for the first three 
of the total four dimensions of operated WHOQOL analysis. The differences obtained could offer an orientation to 
the psychotherapeutically intervention plans and the psycho – oncologic support at the patients suffering of acute 
leukemia. 
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